| Code | 6406B | ||||||||||
| MA number | 44/0429/15-S | ||||||||||
| Product Form: | plc ifo 5x100 mg (liek.inj.skl.jantárová) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Glenmark Pharmaceuticals s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | amber glass container | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.10.2015 |
| SPC: |
SPC_Bendamustine Glenmark 2,5 mg_ml_03.2024.pdf
|
| PIL: |
PIL_Bendamustine Glenmark 2,5 mg_ml_03.2024.pdf
|
| Safety feature | Yes |
| Data update: | 19.06.2020 |
